.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Dow
Farmers Insurance
Teva
Deloitte
Fuji
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson
Accenture

Generated: September 21, 2017

DrugPatentWatch Database Preview

Dalbavancin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dalbavancin hydrochloride and what is the scope of dalbavancin hydrochloride freedom to operate?

Dalbavancin hydrochloride
is the generic ingredient in one branded drug marketed by Allergan Sales Llc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Dalbavancin hydrochloride has fifty-three patent family members in sixteen countries.

One supplier is listed for this compound.

Summary for Generic Name: dalbavancin hydrochloride

Tradenames:1
Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list2,292
Drug Prices:see low prices
DailyMed Link:dalbavancin hydrochloride at DailyMed

Pharmacology for Ingredient: dalbavancin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Allergan Sales Llc
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: dalbavancin hydrochloride

Country Document Number Estimated Expiration
China1711102► Subscribe
South Korea20050094396► Subscribe
New Zealand588109► Subscribe
South Africa200607888► Subscribe
Australia2003299561► Subscribe
Russian Federation2008142899► Subscribe
South Korea20080048093► Subscribe
Israel168327► Subscribe
China101130060► Subscribe
Canada2564112► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Julphar
Novartis
Fuji
Baxter
Covington
Merck
Mallinckrodt
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot